Department of Microbiology, Immunology and Cancer Biology, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Germany.
J Virol. 2020 Jul 30;94(16). doi: 10.1128/JVI.02100-19.
Ebola virus (EBOV) inclusion bodies (IBs) are cytoplasmic sites of nucleocapsid formation and RNA replication, housing key steps in the virus life cycle that warrant further investigation. During infection, IBs display dynamic properties regarding their size and location. The contents of IBs also must transition prior to further viral maturation, assembly, and release, implying additional steps in IB function. Interestingly, the expression of the viral nucleoprotein (NP) alone is sufficient for the generation of IBs, indicating that it plays an important role in IB formation during infection. In addition to NP, other components of the nucleocapsid localize to IBs, including VP35, VP24, VP30, and the RNA polymerase L. We previously defined and solved the crystal structure of the C-terminal domain of NP (NP-Ct), but its role in virus replication remained unclear. Here, we show that NP-Ct is necessary for IB formation when NP is expressed alone. Interestingly, we find that NP-Ct is also required for the production of infectious virus-like particles (VLPs), and that defective VLPs with NP-Ct deletions are significantly reduced in viral RNA content. Furthermore, coexpression of the nucleocapsid component VP35 overcomes deletion of NP-Ct in triggering IB formation, demonstrating a functional interaction between the two proteins. Of all the EBOV proteins, only VP35 is able to overcome the defect in IB formation caused by the deletion of NP-Ct. This effect is mediated by a novel protein-protein interaction between VP35 and NP that controls both regulation of IB formation and RNA replication itself and that is mediated by a newly identified functional domain of NP, the central domain. Inclusion bodies (IBs) are cytoplasmic sites of RNA synthesis for a variety of negative-sense RNA viruses, including Ebola virus. In addition to housing important steps in the viral life cycle, IBs protect new viral RNA from innate immune attack and contain specific host proteins whose function is under study. A key viral factor in Ebola virus IB formation is the nucleoprotein, NP, which also is important in RNA encapsidation and synthesis. In this study, we have identified two domains of NP that control inclusion body formation. One of these, the central domain (CD), interacts with viral protein VP35 to control both inclusion body formation and RNA synthesis. The other is the NP C-terminal domain (NP-Ct), whose function has not previously been reported. These findings contribute to a model in which NP and its interactions with VP35 link the establishment of IBs to the synthesis of viral RNA.
埃博拉病毒 (EBOV) 包含体 (IBs) 是核衣壳形成和 RNA 复制的细胞质部位,包含病毒生命周期中的关键步骤,值得进一步研究。在感染过程中,IBs 在大小和位置方面表现出动态特性。IBs 的内容也必须在进一步的病毒成熟、组装和释放之前转变,这意味着 IB 功能有额外的步骤。有趣的是,单独表达病毒核蛋白 (NP) 就足以产生 IBs,这表明它在感染过程中 IB 形成中发挥重要作用。除了 NP 之外,核衣壳的其他成分也定位于 IBs 中,包括 VP35、VP24、VP30 和 RNA 聚合酶 L。我们之前已经定义并解决了 NP 的 C 末端结构域 (NP-Ct) 的晶体结构,但它在病毒复制中的作用仍不清楚。在这里,我们表明当单独表达 NP 时,NP-Ct 对于 IB 的形成是必需的。有趣的是,我们发现 NP-Ct 对于产生感染性病毒样颗粒 (VLPs) 也是必需的,并且缺失 NP-Ct 的缺陷 VLPs 的病毒 RNA 含量显著降低。此外,核衣壳成分 VP35 的共表达克服了 NP-Ct 缺失触发 IB 形成的缺陷,证明了这两种蛋白之间存在功能相互作用。在所有 EBOV 蛋白中,只有 VP35 能够克服 NP-Ct 缺失引起的 IB 形成缺陷。这种效应是由 VP35 和 NP 之间的新型蛋白-蛋白相互作用介导的,该相互作用不仅控制 IB 的形成和 RNA 复制的调节,还由 NP 的新鉴定的功能域中央结构域介导。包含体 (IBs) 是各种负义 RNA 病毒的 RNA 合成的细胞质部位,包括埃博拉病毒。除了容纳病毒生命周期中的重要步骤外,IBs 还保护新的病毒 RNA 免受先天免疫攻击,并包含特定的宿主蛋白,其功能正在研究中。Ebola 病毒 IB 形成的一个关键病毒因子是核蛋白 NP,它在 RNA 包装和合成中也很重要。在这项研究中,我们已经确定了控制包含体形成的 NP 的两个结构域。其中之一是中央结构域 (CD),它与病毒蛋白 VP35 相互作用,控制包含体形成和 RNA 合成。另一个是 NP C 末端结构域 (NP-Ct),其功能以前没有报道过。这些发现有助于建立一个模型,其中 NP 及其与 VP35 的相互作用将 IBs 的建立与病毒 RNA 的合成联系起来。